Expert Review of Pharmacoeconomics & Outcomes Research, Volume 21, Issue 2 (2021)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 21, Issue 2 (2021)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Volume 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Conducting economic evaluation based on basket clinical trial in the area of precision medicine
Marzieh Nosrati & Shekoufeh Nikfar
Pages: 169-171
Published online: 24 Dec 2020
First Page PreviewforConducting economic evaluation based on basket clinical trial in the area of precision medicine | Full Text | References | PDF (224.8 KB) | EPUB
  • 1404 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Review

Pharmacoeconomics of obesity in China: a scoping review
Zhuo Chen, Shan Jiang, Youfa Wang, M. Mahmud Khan, Donglan Zhang, Janani Rajbhandari-Thapa & Li Li
Pages: 173-181
Published online: 09 Feb 2021
AbstractforPharmacoeconomics of obesity in China: a scoping review | Full Text | References | PDF (359 KB) | EPUB
  • 623 Views
  • 5 CrossRef citations
  • 0Altmetric
Incorporating patients’ preferences in the value assessment of disease-modifying therapies for multiple sclerosis: a narrative review
Surachat Ngorsuraches & Nabin Poudel
Pages: 183-195
Published online: 02 Feb 2021
AbstractforIncorporating patients’ preferences in the value assessment of disease-modifying therapies for multiple sclerosis: a narrative review | Full Text | References | PDF (375.6 KB) | EPUB
  • 187 Views
  • 2 CrossRef citations
  • 0Altmetric
Performance-based risk-sharing agreements in renal care: current experience and future prospects
Michael Drummond, Carlo Federici, Ellen Busink, Christian Apel, Dana Kendzia & Werner Brouwer
Pages: 197-210
Published online: 05 Mar 2021
AbstractforPerformance-based risk-sharing agreements in renal care: current experience and future prospects | Full Text | References | PDF (1.3 MB) | EPUB
  • 1854 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Challenges and opportunities in measuring the pediatric quality of life: exemplified by research in pediatric gastroenterology
Katherine Lamparyk, Kimberly Burkhart, Jessica Buzenski & Miranda A.L. van Tilburg
Pages: 211-219
Published online: 07 Feb 2021
AbstractforChallenges and opportunities in measuring the pediatric quality of life: exemplified by research in pediatric gastroenterology | Full Text | References | PDF (260.7 KB) | EPUB
  • 151 Views
  • 0 CrossRef citations
  • 0Altmetric

Systematic review

The cost-effectiveness of once-weekly semaglutide compared with other GLP-1 receptor agonists in type 2 Diabetes: a systematic literature review
Zhen Ruan, Lisong Yang, Honghao Shi, Xiaomeng Yue, Yao Wang, Miaoying Liang & Hao Hu
Pages: 221-233
Published online: 12 Jan 2021
AbstractforThe cost-effectiveness of once-weekly semaglutide compared with other GLP-1 receptor agonists in type 2 Diabetes: a systematic literature review | Full Text | References | PDF (774.4 KB) | EPUB | Supplemental
  • 589 Views
  • 8 CrossRef citations
  • 0Altmetric
Productivity loss/gain in cost-effectiveness analyses for vaccines: a systematic review
Akira Yuasa, Naohiro Yonemoto, Michael LoPresti & Shunya Ikeda
Pages: 235-245
Published online: 23 Feb 2021
AbstractforProductivity loss/gain in cost-effectiveness analyses for vaccines: a systematic review | Full Text | References | PDF (2.7 MB) | EPUB | Supplemental
  • 2658 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access

Study protocol

Article
Burden of illness of progressive familial intrahepatic cholestasis in the US, UK, France, and Germany: study rationale and protocol of the PICTURE study
Leonardo Ruiz-Casas, Sonia O’Hara, Claudia Mighiu, Alan Finnegan, Alison Taylor, Emily Ventura, Anil Dhawan, Karen F Murray, Jorn Schattenberg, Jose Willemse, Melanie Karakaidos & Harpreet Brrang
Pages: 247-253
Published online: 07 Jan 2021
AbstractforBurden of illness of progressive familial intrahepatic cholestasis in the US, UK, France, and Germany: study rationale and protocol of the PICTURE study | Full Text | References | PDF (1,014.6 KB) | EPUB | Supplemental
  • 3356 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original research

Article
Budget impact analysis of pneumococcal conjugate vaccines in Colombia
Jorge Gomez, Luz Elena Moreno, Dagna Constenla, Diana Caceres & Edisson Rodriguez
Pages: 255-263
Published online: 09 Dec 2020
AbstractforBudget impact analysis of pneumococcal conjugate vaccines in Colombia | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 2052 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Cost-effectiveness analysis of apixaban compared to other direct oral anticoagulants for prevention of stroke in Austrian atrial fibrillation patients
Evelyn Walter, Marco Voit & Gerald Eichhober
Pages: 265-275
Published online: 23 Aug 2020
AbstractforCost-effectiveness analysis of apixaban compared to other direct oral anticoagulants for prevention of stroke in Austrian atrial fibrillation patients | Full Text | References | PDF (3.1 MB) | EPUB | Supplemental
  • 313 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Elderly individuals with diabetes and foot ulcer have a probability for healing despite extensive comorbidity and dependency
Magdalena Annersten Gershater & Jan Apelqvist
Pages: 277-284
Published online: 12 Jun 2020
AbstractforElderly individuals with diabetes and foot ulcer have a probability for healing despite extensive comorbidity and dependency | Full Text | References | PDF (315.3 KB) | EPUB
  • 6490 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost of fremanezumab, erenumab, galcanezumab and onabotulinumtoxinA associated adverse events, for migraine prophylaxis in Spain
Pablo Irimia, Sonia Santos-Lasaosa, Laura García Bujalance, Luis Ramos Pinazo, Darío Rubio-Rodríguez & Carlos Rubio-Terrés
Pages: 285-297
Published online: 02 Jun 2020
AbstractforCost of fremanezumab, erenumab, galcanezumab and onabotulinumtoxinA associated adverse events, for migraine prophylaxis in Spain | Full Text | References | PDF (1.1 MB) | EPUB
  • 338 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Impact of surgical instrumentation on hospital length of stay and cost of total knee arthroplasty
Vicente J. León-Muñoz, Mirian López-López, Francisco Martínez-Martínez & Fernando Santonja-Medina
Pages: 299-305
Published online: 21 Jun 2020
AbstractforImpact of surgical instrumentation on hospital length of stay and cost of total knee arthroplasty | Full Text | References | PDF (672.1 KB) | EPUB
  • 140 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Predictive modeling to identify potential participants of a disease management program hypertension
Pamela Lenti, Stefan Kottmair, Stephanie Stock, Arim Shukri & Dirk Müller
Pages: 307-314
Published online: 30 Jun 2020
AbstractforPredictive modeling to identify potential participants of a disease management program hypertension | Full Text | References | PDF (481.2 KB) | EPUB | Supplemental
  • 152 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Cost of patients with hemophilia A treated with standard half-life or extended half-life FVIII in Spain
Hae Kyung Kim, Carmen Peral, Darío Rubio-Rodríguez & Carlos Rubio-Terrés
Pages: 315-320
Published online: 27 Jul 2020
AbstractforCost of patients with hemophilia A treated with standard half-life or extended half-life FVIII in Spain | Full Text | References | PDF (328.2 KB) | EPUB
  • 2164 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access

Explore articles